Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Merck & Co. claims NMDA and AMPA antagonists for neurologic indications

Jan. 21, 1997

New anticonvulsants from Howard University

Jan. 21, 1997

BMS antidepressant chosen for important multiinstitutional trial

Jan. 20, 1997

Phase II trials begin on ICOS MS treatment

Jan. 20, 1997

Conclusion of Cephalon/Schering-Plough AD collaboration

Jan. 17, 1997

Novel antioxidant disclosed by Nippon Chemiphar

Jan. 17, 1997

Japanese investigators isolate novel aminopeptidase inhibitor

Jan. 17, 1997

New dopamine receptor ligands reported by Roche

Jan. 17, 1997

Avonex update presented

Jan. 16, 1997

Fujisawa characterizes novel antidementia agent

Jan. 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...